Don K. Hamlin

482 total citations
12 papers, 402 citations indexed

About

Don K. Hamlin is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Organic Chemistry. According to data from OpenAlex, Don K. Hamlin has authored 12 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Pathology and Forensic Medicine and 2 papers in Organic Chemistry. Recurrent topics in Don K. Hamlin's work include Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lymphoma Diagnosis and Treatment (5 papers). Don K. Hamlin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lymphoma Diagnosis and Treatment (5 papers). Don K. Hamlin collaborates with scholars based in United States and Sweden. Don K. Hamlin's co-authors include D. Scott Wilbur, Oliver W. Press, Don B. Axworthy, Damon L. Meyer, Robert W. Mallett, Louis Theodore, Patrick S. Stayton, John M. Pagel, Eric Kin Cheong Yau and Timothy A. Johnson and has published in prestigious journals such as Blood, Industrial & Engineering Chemistry Research and Bioconjugate Chemistry.

In The Last Decade

Don K. Hamlin

11 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Don K. Hamlin United States 8 322 122 69 65 57 12 402
Don B. Axworthy United States 11 524 1.6× 204 1.7× 134 1.9× 83 1.3× 85 1.5× 14 634
Catherine Saï-Maurel France 14 323 1.0× 38 0.3× 126 1.8× 84 1.3× 64 1.1× 24 422
Warak Chaovapong United States 7 310 1.0× 36 0.3× 122 1.8× 112 1.7× 30 0.5× 10 405
Fu Su China 7 281 0.9× 74 0.6× 82 1.2× 95 1.5× 32 0.6× 8 390
Stefano Papi Italy 10 182 0.6× 60 0.5× 193 2.8× 47 0.7× 49 0.9× 25 446
N Breiter Germany 10 173 0.5× 24 0.2× 87 1.3× 78 1.2× 112 2.0× 26 409
Gábor Nagy Hungary 11 148 0.5× 61 0.5× 96 1.4× 75 1.2× 59 1.0× 28 363
Alexandre Pichard France 11 194 0.6× 33 0.3× 63 0.9× 56 0.9× 71 1.2× 11 271
J.C. Saccavini France 12 382 1.2× 54 0.4× 104 1.5× 120 1.8× 72 1.3× 25 493
Paul Chinn United States 8 365 1.1× 244 2.0× 140 2.0× 67 1.0× 89 1.6× 11 532

Countries citing papers authored by Don K. Hamlin

Since Specialization
Citations

This map shows the geographic impact of Don K. Hamlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don K. Hamlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don K. Hamlin more than expected).

Fields of papers citing papers by Don K. Hamlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don K. Hamlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don K. Hamlin. The network helps show where Don K. Hamlin may publish in the future.

Co-authorship network of co-authors of Don K. Hamlin

This figure shows the co-authorship network connecting the top 25 collaborators of Don K. Hamlin. A scholar is included among the top collaborators of Don K. Hamlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don K. Hamlin. Don K. Hamlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Green, Damian J., Jon C. Jones, Yukang Lin, et al.. (2015). A Novel Bispecific CD38 Antibody Eradicates Multiple Myeloma in a Mouse Model Following Yttrium-90-DOTA Capture. Blood. 126(23). 118–118. 1 indexed citations
2.
Kenoyer, Aimee L., Yukang Lin, Johnnie J. Orozco, et al.. (2014). Pre-Targeted Radioimmunotherapy Employing a Recombinant Bispecific Antibody Using a Murine Xenograft Model of Human Leukemia. Blood. 124(21). 3749–3749. 2 indexed citations
4.
Pagel, John M., Anastasia Pantelias, Yukang Lin, et al.. (2006). Conventional and Pretargeted Radioimmunotherapy Using an Anti-Murine CD45 Monoclonal Antibody in a Syngeneic, Disseminated Murine Leukemia Model.. Blood. 108(11). 570–570. 3 indexed citations
7.
Hamblett, Kevin J., Oliver W. Press, Damon L. Meyer, et al.. (2004). Role of Biotin-Binding Affinity in Streptavidin-Based Pretargeted Radioimmunotherapy of Lymphoma. Bioconjugate Chemistry. 16(1). 131–138. 27 indexed citations
8.
Hamlin, Don K., John M. Pagel, D. Scott Wilbur, et al.. (2003). Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.. PubMed. 44(3). 437–45. 57 indexed citations
9.
Hamblett, Kevin J., Don K. Hamlin, Ming‐Kuan Chyan, et al.. (2002). A Streptavidin−Biotin Binding System That Minimizes Blocking by Endogenous Biotin. Bioconjugate Chemistry. 13(3). 588–598. 53 indexed citations
10.
Press, Oliver W., Don K. Hamlin, D. Scott Wilbur, et al.. (2001). A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts. Blood. 98(8). 2535–2543. 121 indexed citations
11.
Tingey, Joel M., Oleg B. Egorov, T.S. Tenforde, et al.. (2000). Development of a Unique Bismuth (Bi-213) Automated Generator for Use in Cancer Therapy. Industrial & Engineering Chemistry Research. 39(9). 3189–3194. 27 indexed citations
12.
Reed, Michael W., et al.. (1997). Synthesis of 125I-Labeled Oligonucleotides from Tributylstannylbenzamide Conjugates. Bioconjugate Chemistry. 8(2). 238–243. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026